![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1621359 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SBNO2 mRNA | CTD | PMID:36331819 | 17beta-estradiol | increases expression | ISO | RGD:1316240 | 6480464 | Estradiol results in increased expression of SBNO2 mRNA | CTD | PMID:23019147 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1621359 | 6480464 | Tetrachlorodibenzodioxin affects the expression of SBNO2 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SBNO2 mRNA | CTD | PMID:33387578 | 4,4'-sulfonyldiphenol | increases methylation | ISO | RGD:1621359 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased methylation of SBNO2 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1316240 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of SBNO2 gene | CTD | PMID:31601247 | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1621359 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of SBNO2 mRNA | CTD | PMID:19191707 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1621359 | 6480464 | Fenretinide results in increased expression of SBNO2 mRNA | CTD | PMID:28973697 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1621359 | 6480464 | Fenretinide results in decreased expression of SBNO2 mRNA | CTD | PMID:28973697 | acrylamide | decreases expression | ISO | RGD:1316240 | 6480464 | Acrylamide results in decreased expression of SBNO2 mRNA | CTD | PMID:32763439 | aflatoxin B1 | increases methylation | ISO | RGD:1316240 | 6480464 | Aflatoxin B1 results in increased methylation of SBNO2 intron | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | RGD:1316240 | 6480464 | aflatoxin B2 results in increased methylation of SBNO2 intron | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | RGD:1316240 | 6480464 | Tretinoin results in increased expression of SBNO2 mRNA | CTD | PMID:33167477 | antirheumatic drug | decreases expression | ISO | RGD:1316240 | 6480464 | Antirheumatic Agents results in decreased expression of SBNO2 mRNA | CTD | PMID:24449571 | aripiprazole | multiple interactions | ISO | RGD:1316240 | 6480464 | [Aripiprazole co-treated with Ozone] results in increased expression of SBNO2 mRNA | CTD | PMID:31476115 | aristolochic acid A | increases expression | ISO | RGD:1316240 | 6480464 | aristolochic acid I results in increased expression of SBNO2 mRNA | CTD | PMID:33212167 | aristolochic acid A | decreases expression | ISO | RGD:1316240 | 6480464 | aristolochic acid I results in decreased expression of SBNO2 protein | CTD | PMID:33212167 | arsane | affects expression | ISO | RGD:1316240 | 6480464 | Arsenic affects the expression of SBNO2 mRNA | CTD | PMID:25304211 | arsane | affects methylation | ISO | RGD:1316240 | 6480464 | Arsenic affects the methylation of SBNO2 gene | CTD | PMID:25304211 | arsenic atom | affects expression | ISO | RGD:1316240 | 6480464 | Arsenic affects the expression of SBNO2 mRNA | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1316240 | 6480464 | Arsenic affects the methylation of SBNO2 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | RGD:1316240 | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SBNO2 mRNA] | CTD | PMID:32406909 | benzo[a]pyrene | increases expression | ISO | RGD:1621359 | 6480464 | Benzo(a)pyrene results in increased expression of SBNO2 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | RGD:1316240 | 6480464 | Benzo(a)pyrene affects the methylation of SBNO2 5' UTR, Benzo(a)pyrene affects the methylation of SBNO2 intron | CTD | PMID:27901495, PMID:30157460 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SBNO2 mRNA | CTD | PMID:25181051 more ... | bisphenol A | decreases methylation | ISO | RGD:1316240 | 6480464 | bisphenol A results in decreased methylation of SBNO2 gene | CTD | PMID:31601247 | bisphenol A | multiple interactions | ISO | RGD:1316240 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SBNO2 gene | CTD | PMID:31601247 | bisphenol F | multiple interactions | ISO | RGD:1316240 | 6480464 | [bisphenol F co-treated with Fulvestrant] results in increased methylation of SBNO2 gene | CTD | PMID:31601247 | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of SBNO2 mRNA | CTD | PMID:19167457 | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of SBNO2 promoter | CTD | PMID:22457795 | carbon nanotube | increases expression | ISO | RGD:1621359 | 6480464 | Nanotubes more ... | CTD | PMID:25554681, PMID:25620056 | choline | multiple interactions | ISO | RGD:1621359 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SBNO2 mRNA | CTD | PMID:20938992 | clobetasol | decreases expression | ISO | RGD:1621359 | 6480464 | Clobetasol results in decreased expression of SBNO2 mRNA | CTD | PMID:27462272 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of SBNO2 mRNA | CTD | PMID:27523638 | cyclosporin A | increases expression | ISO | RGD:1316240 | 6480464 | Cyclosporine results in increased expression of SBNO2 mRNA | CTD | PMID:25562108 | diazinon | increases methylation | ISO | RGD:1316240 | 6480464 | Diazinon results in increased methylation of SBNO2 gene | CTD | PMID:22964155 | dicrotophos | increases expression | ISO | RGD:1316240 | 6480464 | dicrotophos results in increased expression of SBNO2 mRNA | CTD | PMID:28302478 | fluoranthene | multiple interactions | ISO | RGD:1621359 | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in increased expression of SBNO2 mRNA | CTD | PMID:28329830 | folic acid | multiple interactions | ISO | RGD:1621359 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SBNO2 mRNA | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | RGD:1316240 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SBNO2 gene, [bisphenol F co-treated with Fulvestrant] results in increased methylation of SBNO2 gene | CTD | PMID:31601247 | fulvestrant | increases methylation | ISO | RGD:1316240 | 6480464 | Fulvestrant results in increased methylation of SBNO2 gene | CTD | PMID:31601247 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of SBNO2 mRNA | CTD | PMID:33387578 | isoprenaline | increases expression | ISO | RGD:1621359 | 6480464 | Isoproterenol results in increased expression of SBNO2 mRNA | CTD | PMID:20003209 | L-methionine | multiple interactions | ISO | RGD:1621359 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SBNO2 mRNA | CTD | PMID:20938992 | lead diacetate | increases expression | ISO | RGD:1621359 | 6480464 | lead acetate results in increased expression of SBNO2 mRNA | CTD | PMID:20542052 | methotrexate | decreases expression | ISO | RGD:1316240 | 6480464 | Methotrexate results in decreased expression of SBNO2 mRNA | CTD | PMID:24449571 | nickel atom | increases expression | ISO | RGD:1316240 | 6480464 | Nickel results in increased expression of SBNO2 mRNA | CTD | PMID:24768652, PMID:25583101 | ozone | multiple interactions | ISO | RGD:1316240 | 6480464 | [Aripiprazole co-treated with Ozone] results in increased expression of SBNO2 mRNA | CTD | PMID:31476115 | ozone | increases expression | ISO | RGD:1316240 | 6480464 | Ozone results in increased expression of SBNO2 mRNA | CTD | PMID:31476115 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SBNO2 mRNA | CTD | PMID:33387578 | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of SBNO2 mRNA | CTD | PMID:32680482 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1621359 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SBNO2 mRNA | CTD | PMID:36331819 | pirinixic acid | increases expression | ISO | RGD:1621359 | 6480464 | pirinixic acid results in increased expression of SBNO2 mRNA | CTD | PMID:18301758 | propiconazole | decreases expression | ISO | RGD:1621359 | 6480464 | propiconazole results in decreased expression of SBNO2 mRNA | CTD | PMID:21278054 | sodium arsenate | decreases expression | ISO | RGD:1621359 | 6480464 | sodium arsenate results in decreased expression of SBNO2 mRNA | CTD | PMID:30953684 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SBNO2 mRNA | CTD | PMID:19281266 | sunitinib | increases expression | ISO | RGD:1316240 | 6480464 | Sunitinib results in increased expression of SBNO2 mRNA | CTD | PMID:31533062 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SBNO2 mRNA | CTD | PMID:34492290 | titanium dioxide | affects expression | ISO | RGD:1621359 | 6480464 | titanium dioxide affects the expression of SBNO2 mRNA | CTD | PMID:17656681 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SBNO2 mRNA | CTD | PMID:33387578 | Triptolide | increases expression | ISO | RGD:1621359 | 6480464 | triptolide results in increased expression of SBNO2 mRNA | CTD | PMID:32835833 | triptonide | decreases expression | ISO | RGD:1621359 | 6480464 | triptonide results in decreased expression of SBNO2 mRNA | CTD | PMID:33045310 | tungsten | decreases expression | ISO | RGD:1621359 | 6480464 | Tungsten results in decreased expression of SBNO2 mRNA | CTD | PMID:30912803 | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of SBNO2 mRNA | CTD | PMID:24136188 | valproic acid | increases methylation | ISO | RGD:1316240 | 6480464 | Valproic Acid results in increased methylation of SBNO2 gene | CTD | PMID:29154799 | zoledronic acid | increases expression | ISO | RGD:1316240 | 6480464 | zoledronic acid results in increased expression of SBNO2 protein | CTD | PMID:28871336 | |